Home NEWS EU announces latest vaccine contract with Moderna

EU announces latest vaccine contract with Moderna

by FAMOUS REPORTERS
0 comment 14 views
Kindly Share This Story

This picture taken on November 18, 2020 shows a syringe and a bottle reading “Vaccine Covid-19” next to the Moderna biotech company logo. – The CEO of Moderna warned European countries on November 17 that dragging out negotiations to purchase its promising new Covid-19 vaccine will slow down deliveries, as other nations that have signed deals will get priority. The biotech company Pfizer said the day after that a completed study of its experimental Covid-19 vaccine showed it is 95 percent effective, after Moderna said its own vaccine was 94.5 percent effective, according to a preliminary analysis. (Photo by JOEL SAGET / AFP) /

The EU said Tuesday it would sign a sixth contract for an upcoming coronavirus vaccine, this time for up to 160 million doses of a jab developed by US firm Moderna.

READ MORE:  Underdevelopment, weak institutional reforms bane of nation building in Nigeria - Ex SGF Anyim

“According to the results of clinical trials, this vaccine could be highly effective against Covid-19,” European Commission President Ursula von der Leyen said.

“Once the vaccine is indeed proven as safe and effective, every member state will receive it at the same time on a pro rata basis,” she said, in a brief statement.

READ MORE:  Tunisia cracks down with arrests in Italy hazardous waste scandal

Details of the contract, including any purchase options within the 160 million possible total number of doses, will be announced when it is signed on Wednesday.

Brussels has previously signed contracts for hundreds of millions of doses of possible future vaccines from Johnson & Johnson, Sanofi-GSK, AstraZeneca, Pfizer-BionNTech and CureVac.

Von der Leyen has said that the European Medicines Agency may next month give approval for the most promising vaccines, that have already submitted data from clinical trials.

“Between us we are setting up one of the most comprehensive Covid-19 vaccine portfolios in the world. This provides Europeans access to the most promising future vaccines under development so far,” she said.

“Of course, all vaccines from our portfolio will be evaluated very carefully by our European Medicines Agency, the EMA,” she added.

“They will be only authorised and placed on the market if they are safe and if they are effective. Transparency here is crucial and of utmost importance.”



You may also like

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy